Stereotactic Body Radiation Therapy for Lung and Liver Oligometastases from Breast Cancer: Toxicity Data of a Prospective Non-Randomized Phase II Trial

Stereotactic Body Radiation Therapy for Lung and Liver Oligometastases from Breast Cancer: Toxicity Data of a Prospective Non-Randomized Phase II Trial

Aims: We report the mature toxicity data of a phase II non-randomized trial on the use of SBRT for lung and liver oligometastases. Methods: Oligometastatic patients from breast cancer were treated with SBRT for up to five lung and/or liver lesions. Inclusion criteria were: age > 18 years, ECOG 0–...

Full description

Bibliographic Details
Main Authors: Davide Franceschini, Tiziana Comito, Anna Di Gallo, Veronica Vernier, Marco A. Marzo, Luciana Di Cristina, Beatrice Marini, Lorenzo Lo Faro, Sara Stefanini, Ruggero Spoto, Luca Dominici, Ciro Franzese, Marta Scorsetti
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Current Oncology
Subjects:
stereotactic body radiotherapy
oligometastases
breast cancer
phase II
toxicity
Online Access:https://www.mdpi.com/1718-7729/29/10/621

Internet

https://www.mdpi.com/1718-7729/29/10/621

Similar Items